Bio-Connect
IHC-P analysis of human brain tissue using GTX85431 CDNF antibody. Working concentration : 5 microg/ml
IHC-P analysis of human brain tissue using GTX85431 CDNF antibody. Working concentration : 5 microg/ml
IHC-P analysis of human brain tissue using GTX85431 CDNF antibody. Working concentration : 5 microg/ml

CDNF antibody

GTX85431
GeneTex
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetCDNF
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CDNF antibody
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody does not cross-react with MANF.
  • Application Supplier Note
    WB: 1 microg/mL. IHC-P: 5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID441549
  • Target name
    CDNF
  • Target description
    cerebral dopamine neurotrophic factor
  • Target synonyms
    arginine-rich, mutated in early stage tumors-like 1; ARMETL1; ARMET-like protein 1; cerebral dopamine neurotrophic factor; conserved dopamine neurotrophic factor
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ49AH0
  • Protein Name
    Cerebral dopamine neurotrophic factor
  • Scientific Description
    The conserved dopamine neurotrophic factor (CDNF) is a neurotrophic factor for dopaminergic neurons and highly homologous to the mesencephalic-astrocyte-derived neuro-trophic factor. Somewhat surprisingly, CDCF is expressed at higher levels in tissues such as heart, skeletal muscle and testes than in brain. Similar to the glial cell line-derived neurotrophic factor (GDNF), CDNF can prevent the 6-hydroxylamine (6-OHDA)-induced degeneration of dopaminergic neurons in a rat model of Parkinsons disease. Furthermore, CDNF was able to restore the dopaminergic function and prevent the degeneration of dopaminergic neurons in the substantia nigra, suggesting that CDNF might be suitable for the treatment of Parkinsons disease. At least two isoforms of CDNF are known to exist. This antibody does not cross-react with MANF.
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203